Lupin arm recalls 5,720 tubes of Clobetasol propionate Cream in US over manufacturing issue Ruchika Sharma6 Feb 2023 5:56 AM GMTThe USFDA noted that the company is recalling the affected lot due to "Subpotent Drug: Low assay result observed during long-term stability testing".
Lupin bags tentative USFDA nod for Dolutegravir, Emtricitabine and Tenofovir Alafenamide Tablets to control HIV infections Ruchika Sharma31 Jan 2023 10:00 AM GMTMumbai: Global pharma major Lupin Limited today announced that it has received tentative approval from the United States Food and Drug...
Lupin recalls 16,056 bottles of tuberculosis drug Rifampin in US Ruchika Sharma21 Jan 2023 9:19 AM GMTThe affected lot has been produced at Lupin's Aurangabad plant and marketed in the US by Baltimore-based Lupin Pharmaceuticals.
Lupin bags USFDA nod for Dolutegravir, Rilpivirine tablets to treat HIV infection Ruchika Sharma16 Jan 2023 9:50 AM GMTMumbai: Global pharma major Lupin Limited today announced that it has received tentative approval from the United States Food and Drug Administration...
Lupin gets 2 USFDA observations for Somerset facility Ruchika Sharma16 Jan 2023 7:45 AM GMTMumbai: Lupin has announced that the company has received two observations from the US Food and Drug Administration (USFDA) at the closure of...
Lupin secures USFDA okay for Prasugrel tablets used in heart ailments Ruchika Sharma11 Jan 2023 6:36 AM GMTMumbai: Global pharma major Lupin Limited has announced that it has received approval from the United States Food and Drug Administration (U.S. FDA)...
Lupin bags USFDA approval for Fesoterodine Fumarate ER Tablets Ruchika Sharma10 Jan 2023 9:52 AM GMTMumbai: Global pharma major Lupin Limited has announced that it has received approval from the United States Food and Drug Administration (USFDA) for...
Spain approves reimbursement of Lupin NaMuscla for symptomatic treatment of myotonia in adults with non-dystrophic myotonic disorders Ruchika Sharma10 Jan 2023 6:05 AM GMTNDM disorders are a group of rare, inherited neuromuscular disorders with an estimated prevalence of 1 case per 100,000 inhabitants in Spain, and is...
Lupin unveils fixed-dose triple drug combination DIFIZMA DPI for inadequately controlled asthma Ruchika Sharma6 Jan 2023 6:08 AM GMT"DIFIZMA is the only FDC that has been approved by the Drug Controller General of India (DCGI) for the treatment of inadequately controlled Asthma,"...
Lupin arm recalls high BP drug Quinapril in US over presence of nitrosamine impurity Ruchika Sharma23 Dec 2022 7:00 AM GMTThe company advised patients taking the Quinapril tablets "to continue taking their medication and contact their pharmacist, physician, or medical...
Lupin Diagnostics launches Regional Reference Laboratory in Indore Ruchika Sharma21 Dec 2022 10:52 AM GMTIndore: Pharma major Lupin Limited announced today the launch of its Regional Reference Laboratory in Indore, Madhya Pradesh, as part of its...
Lupin bags USFDA nod for generic equivalent of Briviact Tablets Ruchika Sharma21 Dec 2022 8:15 AM GMTThe product will be manufactured at Lupin's facility in Nagpur, India.
